{"id":{"repo_id":"wvu","oai_identifier":"oai:researchrepository.wvu.edu:etd-2475"},"canonical_url":"https://search.dev.ndltd.org/etd/wvu/oai:researchrepository.wvu.edu:etd-2475","repository":{"repo_id":"wvu","name":"West Virginia University","base_url":"https://researchrepository.wvu.edu/do/oai/"},"display":{"title":"Perceived efficacy and utilization of the OralCDx brush biopsy","abstract":"The OralCDx is a preliminary screening tool developed to identify suspicious lesions. Despite large numbers of persons diagnosed with oral cancers annually, minimal research has been conducted on the efficacy and utilization rates of OralCDx. The purpose of this study is to determine perceived efficacy and utilization rates of OralCDx nationwide. A 16-item survey was used to survey a random sample of 100 dentists and a 6-item survey was used to survey a random sample of 400 patients. Data analyses were conducted using frequencies, cumulative frequencies, percents, analysis of variance, and tests of chi-square using the JMP program. Preliminary results revealed that 54% of the dentists had high/extremely high confidence in the accuracy of the results. Preliminary results revealed 81% of the patients reported no pain involvement with OralCDx. It can be concluded form this study that OralCDx is accepted by both dentists and patients as a non-invasive screening tool.","abstract_html":"The OralCDx is a preliminary screening tool developed to identify suspicious lesions. Despite large numbers of persons diagnosed with oral cancers annually, minimal research has been conducted on the efficacy and utilization rates of OralCDx. The purpose of this study is to determine perceived efficacy and utilization rates of OralCDx nationwide. A 16-item survey was used to survey a random sample of 100 dentists and a 6-item survey was used to survey a random sample of 400 patients. Data analyses were conducted using frequencies, cumulative frequencies, percents, analysis of variance, and tests of chi-square using the JMP program. Preliminary results revealed that 54% of the dentists had high/extremely high confidence in the accuracy of the results. Preliminary results revealed 81% of the patients reported no pain involvement with OralCDx. It can be concluded form this study that OralCDx is accepted by both dentists and patients as a non-invasive screening tool.","abstract_has_math":false,"creators":["Huffman, Courtney Niccole"],"institution":null,"degree_name":"MS","degree_level":"Thesis","degree_discipline":"Not Listed","degree_department":null,"school":null,"contributors":["Christina B. DeBiase."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2002,"date_issued":"2002-05-01T07:00:00Z","date_published":"2002-05-01T07:00:00Z","updated_at":"2026-07-24T06:15:47Z","subjects":["Dentistry","Oncology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://researchrepository.wvu.edu/etd/1472"],"render_values":[{"text":"https://researchrepository.wvu.edu/etd/1472","href":"https://researchrepository.wvu.edu/etd/1472","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.33915/etd.1472","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Christina B. DeBiase."]},{"key":"dc:creator","label":"Author","values":["Huffman, Courtney Niccole"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-01-17T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Not Listed"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Dentistry","Oncology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://doi.org/10.33915/etd.1472","https://researchrepository.wvu.edu/etd/1472"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The OralCDx is a preliminary screening tool developed to identify suspicious lesions. Despite large numbers of persons diagnosed with oral cancers annually, minimal research has been conducted on the efficacy and utilization rates of OralCDx. The purpose of this study is to determine perceived efficacy and utilization rates of OralCDx nationwide. A 16-item survey was used to survey a random sample of 100 dentists and a 6-item survey was used to survey a random sample of 400 patients. Data analyses were conducted using frequencies, cumulative frequencies, percents, analysis of variance, and tests of chi-square using the JMP program. Preliminary results revealed that 54% of the dentists had high/extremely high confidence in the accuracy of the results. Preliminary results revealed 81% of the patients reported no pain involvement with OralCDx. It can be concluded form this study that OralCDx is accepted by both dentists and patients as a non-invasive screening tool."]},{"key":"dc:title","label":"Title","values":["Perceived efficacy and utilization of the OralCDx brush biopsy"]}]}],"canonical_facts":{"dc:contributor":["Christina B. DeBiase."],"dc:creator":["Huffman, Courtney Niccole"],"dc:date.available":["2019-01-17T08:00:00Z"],"dc:description.abstract":["The OralCDx is a preliminary screening tool developed to identify suspicious lesions. Despite large numbers of persons diagnosed with oral cancers annually, minimal research has been conducted on the efficacy and utilization rates of OralCDx. The purpose of this study is to determine perceived efficacy and utilization rates of OralCDx nationwide. A 16-item survey was used to survey a random sample of 100 dentists and a 6-item survey was used to survey a random sample of 400 patients. Data analyses were conducted using frequencies, cumulative frequencies, percents, analysis of variance, and tests of chi-square using the JMP program. Preliminary results revealed that 54% of the dentists had high/extremely high confidence in the accuracy of the results. Preliminary results revealed 81% of the patients reported no pain involvement with OralCDx. It can be concluded form this study that OralCDx is accepted by both dentists and patients as a non-invasive screening tool."],"dc:identifier":["https://doi.org/10.33915/etd.1472","https://researchrepository.wvu.edu/etd/1472"],"dc:subject":["Dentistry","Oncology"],"dc:title":["Perceived efficacy and utilization of the OralCDx brush biopsy"],"thesis:degree_discipline":["Not Listed"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["MS"]},"updated_at":"2026-07-24T06:15:47Z"}